BHWM
ARKG icon

Bay Harbor Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bay Harbor Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed -$1.4K – 170
2023
Q3 		$1.4K Hold
50
– – ﹤0.01% 148
2023
Q2 		$1.72K Hold
50
– – ﹤0.01% 151
2023
Q1 		$1.51K Hold
50
– – ﹤0.01% 148
2022
Q4 		$1K Hold
50
– – ﹤0.01% 176
2022
Q3 		$2K Hold
50
– – ﹤0.01% 157
2022
Q2 		$2K Hold
50
– – ﹤0.01% 158
2022
Q1 		$2K Buy
+50
New +$2.38K ﹤0.01% 166

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MM
Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bay Harbor Wealth Management's ARKG Position: Q4 2023 in Review

Bay Harbor Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 50 shares — an estimated $1.4K sold.

Bay Harbor Wealth Management first reported a position in ARKG in Q1 2022 and held it in 7 quarters. The position peaked at $2K in Q3 2022. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Bay Harbor Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 50 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $1.4K.
  • Bay Harbor Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 7 quarters.
  • Bay Harbor Wealth Management's ARK Genomic Revolution ETF position peaked at $2K in Q3 2022.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Bay Harbor Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.